Skip to main content

Advertisement

Log in

Donor-specific HLA antibodies and graft function in children after renal transplantation

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

The presence of circulating donor-specific human leukocyte antigen antibodies (HLA-DSA) has been associated with chronic antibody-mediated rejection, leading to progressive graft dysfunction and poor graft survival. The aim of this study was to investigate the incidence and significance of HLA-DSA in paediatric renal transplantation (RTx) patients.

Methods

A total of 294 post-transplant serum samples from 123 RTx patients were retrospectively analysed for HLA antibodies. Positive samples were further tested for HLA-DSA by a Luminex Single Antigen bead assay. The antibody findings were correlated to measured glomerular filtration rate (GFR) and clinical outcome.

Results

HLA antibodies were detected in half of the routine samples (140/294) taken 1 month to 10 years after RTx, and 40% (62/140) of these were HLA-DSA. Overall, one-third (42/123) of the patients had HLA-DSA, which mostly (65%) reacted against class II antigens. Detection of HLA-DSA was not associated with poor GFR at the time of sampling, and no exceptional deterioration of GFR after the HLA-DSA detection was noted in individual patients regardless of the antibody level. The presence of HLA-DSA in the first 2 years posttransplantation was not associated with poorer graft function later on.

Conclusion

Detection of HLA antibodies is common in children after RTx, and this finding, as such, does not predict any deterioration of graft function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

CAMR:

Chronic antibody mediated rejection

CDC:

Complement-dependent lymphocytotoxicity crossmatch

CMV:

Cytomegalovirus

CNF:

Congenital nephrotic syndrome

51Cr-EDTA:

51Chromium-labeled ethylenediaminetetraacetic acid

HLAab:

Human leukocyte antigen antibodies

HLA-DSA:

Donor-specific HLA antibodies

HLA-nonDSA:

HLA antibodies not specific against donor antigens

MFI:

Mean fluorescence intensity

PCR-SSP:

Sequence specific primers and PCR

RTx:

Renal transplantation

References

  1. Meier-Kriesche HU, Schold JD, Kaplan B (2004) Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 4:1289–1295

    Article  PubMed  Google Scholar 

  2. Gaston RS, Cecka JM, Kasiske BL, Fieberg AM, Leduc R, Cosio FC, Gourishankar S, Grande J, Halloran P, Hunsicker L, Mannon R, Rush D, Matas AJ (2010) Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 90:68–74

    Article  PubMed  CAS  Google Scholar 

  3. Nankivell BJ, Borrows RJ, Fung CL, O’Connell PJ, Allen RD, Chapman JR (2003) The natural history of chronic allograft nephropathy. N Engl J Med 349:2326–2333

    Article  PubMed  CAS  Google Scholar 

  4. Akalin E, Pascual M (2006) Sensitization after kidney transplantation. Clin J Am Soc Nephrol 1:433–440

    Article  PubMed  CAS  Google Scholar 

  5. Terasaki PI, Cai J (2008) Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation 86:377–383

    Article  PubMed  Google Scholar 

  6. Böhmig GA, Bartel G, Regele H, Wahrmann M (2009) Prospects and limitations of post-transplantation alloantibody detection in renal transplantation. Hum Immunol 70:640–644

    Article  PubMed  Google Scholar 

  7. Jordan SC, Reinsmoen N, Peng A, Lai CH, Cao K, Villicana R, Toyoda M, Kahwaji J, Vo AA (2010) Advances in diagnosing and managing antibody-mediated rejection. Pediatr Nephrol 25:2035–2045

    Article  PubMed  Google Scholar 

  8. Riethmüller S, Ferrari-Lacraz S, Müller MK, Raptis DA, Hadaya K, Rüsi B, Laube G, Schneiter G, Fehr T, Villard J (2010) Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation. Transplantation 90:160–167

    Article  PubMed  Google Scholar 

  9. Cai J, Terasaki PI (2008) Post-transplantation antibody monitoring and HLA antibody epitope identification. Curr Opin Immunol 20:602–606

    Article  PubMed  CAS  Google Scholar 

  10. Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C (2009) Anti-human leukocyte antigen and donor-specific antibodies detected by Luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 87:1505–1513

    Article  PubMed  CAS  Google Scholar 

  11. Hourmant M, Cesbron-Gautier A, Terasaki PI, Mizutani K, Moreau A, Meurette A, Dantal J, Giral M, Blancho G, Cantarovich D, Karam G, Follea G, Soulillou JP, Bignon JD (2005) Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 16:2804–2812

    Article  PubMed  CAS  Google Scholar 

  12. Claas FH (2010) Clinical relevance of circulating donor-specific HLA antibodies. Curr Opin Organ Transplant 15:462–466

    Article  PubMed  Google Scholar 

  13. Lee PC, Terasaki PI, Takemoto SK, Lee PH, Hung CJ, Chen YL, Tsai A, Lei HY (2002) All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 74:1192–1194

    Article  PubMed  CAS  Google Scholar 

  14. Terasaki PI, Ozawa M, Castro R (2007) Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 7:408–415

    Article  PubMed  CAS  Google Scholar 

  15. Phelan D, Mohanakumar T, Ramachandran S, Jendrisak MD (2009) Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay. Hum Immunol 70:584–588

    Article  PubMed  CAS  Google Scholar 

  16. Aubert V, Venetz JP, Pantaleo G, Pascual M (2009) Are all donor-specific antibodies detected by solid-phase assay before transplantation clinically relevant? Transplantation 87:1897–1898

    Article  PubMed  Google Scholar 

  17. Bartel G, Regele H, Wahrmann M, Huttary N, Exner M, Hörl WH, Böhmig GA (2008) Posttransplant HLA alloreactivity in stable kidney transplant recipients-incidences and impact on long-term allograft outcomes. Am J Transplant 8:2652–2660

    Article  PubMed  CAS  Google Scholar 

  18. Süsal C, Ovens J, Mahmoud K, Döhler B, Scherer S, Ruhenstroth A, Tran TH, Heinoid A, Opelz G (2011) No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a Collaborative Transplant Study report. Transplantation 91:883–887

    Article  PubMed  Google Scholar 

  19. Girnita AL, Webber SA, Zeevi A (2006) Anti-HLA alloantibodies in pediatric solid organ transplantation. Pediatr Transplant 10:146–153

    Article  PubMed  CAS  Google Scholar 

  20. Roberti I, Vyas S, Pancoska C (2007) Donor-specific antibodies by flow single antigen beads in pediatric living donor kidney transplants: single center experience. Pediatr Transplant 11:901–905

    Article  PubMed  Google Scholar 

  21. Verghese PS, Smith JM, McDonald RA, Schwartz SM, Nelson KA, Warner PR (2010) Impaired graft survival in pediatric renal transplant recipients with donor-specific antibodies detected by solid-phase assays. Pediatr Transplant 14:730–734

    Article  PubMed  Google Scholar 

  22. Emonds MP, Herman J, Dendievel J, Waer M, Van Damme-Lombaerts R (2000) Evaluation of anti-human leukocyte antigen allo-immunization in pediatric cadaveric kidney transplantation. Pediatr Transplant 4:6–11

    Article  PubMed  CAS  Google Scholar 

  23. Valta H, Jalanko H, Holmberg C, Helenius I, Mäkitie O (2008) Impaired bone health in adolescents after liver transplantation. Am J Transplant 8:150–157

    PubMed  CAS  Google Scholar 

  24. Jodal L, Brochner-Mortensen J (2009) Reassessment of a classical single injection 51Cr-EDTA clearance method for determination of renal function in children and adults. Part I: Analytically correct relationship between total and one-pool clearance. Scand J Clin Lab Invest 69:305–313

    Article  PubMed  Google Scholar 

  25. Eng HS, Bennett G, Bardy P, Coghlan P, Russ GR, Coates PT (2009) Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools. Hum Immunol 70:595–599

    Article  PubMed  CAS  Google Scholar 

  26. Terasaki P, Lachmann N, Cai J (2006) Summary of the effect of de novo HLA antibodies on chronic kidney graft failure. Clin Transpl 455–462

  27. Amico P, Hönger G, Mayr M, Steiger J, Hopfer H, Schaub S (2009) Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 87:1681–1688

    Article  PubMed  CAS  Google Scholar 

  28. Gupta A, Sinnott P (2009) Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor. Hum Immunol 70:618–622

    Article  PubMed  CAS  Google Scholar 

  29. Fine RN, Malekzadeh MH, Pennisi AJ, Ettenger RB, Uittenbogaart CH, Korsch BM (1979) Renal transplantation in children. J Pediatr 95:244–248

    Article  PubMed  CAS  Google Scholar 

  30. Davenport A, Younie ME, Parsons JE, Klouda PT (1994) Development of cytotoxic antibodies following renal allograft transplantation is associated with reduced graft survival due to chronic vascular rejection. Nephrol Dial Transplant 9:1315–1319

    PubMed  CAS  Google Scholar 

  31. Yabu JM, Higgins JP, Chen G, Sequeira F, Busque S, Tyran DB (2011) C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation. Transplantation 91:342–347

    Article  PubMed  CAS  Google Scholar 

  32. Chin C, Chen G, Sequeria F, Berry G, Siehr S, Bernstein D, Rosenthal D, Reinhartz O, Tyan D (2011) Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant 30:158–163

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jenni Miettinen.

Additional information

Jenni Miettinen and Juha Peräsaari contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miettinen, J., Peräsaari, J., Lauronen, J. et al. Donor-specific HLA antibodies and graft function in children after renal transplantation. Pediatr Nephrol 27, 1011–1019 (2012). https://doi.org/10.1007/s00467-012-2101-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-012-2101-4

Keywords

Navigation